{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:11:19Z","timestamp":1788718279485,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anticoagulation is an essential component of optimal extracorporeal membrane oxygenation (ECMO) management. Unfractionated heparin is still the anticoagulant of choice in most centers due to longstanding familiarity with the agent. Disadvantages include alterations in drug responses due to its capability to bind multiple heparin-binding proteins that compete with antithrombin and the potential for heparin-induced thrombocytopenia. In such cases, direct thrombin inhibitors are the treatment of choice but pose difficulties in monitoring due to the limited experience and target ranges for non-aPTT-guided management (aPTT: activated partial thromboplastin time). The current trend toward low-dose anticoagulation, especially for venovenous ECMO, is supported by data associating bleeding complications with mortality but not thromboembolic events, which include circuit thrombosis. However, only prospective data will provide appropriate answers to how to individualize anticoagulation, transfusions, and bleeding management which is currently only supported by expert opinion. Empiric therapy for ECMO patients based on laboratory coagulation alone should always be critically questioned. In summary, only collaboration and future studies of coagulation management during ECMO will help us to make this life-saving therapy that has become part of daily life of the intensivist even safer and more effective. Until then, a\u00a0fundamental understanding of coagulation and bleeding management, as well as pearls and pitfalls of monitoring, is essential to optimize anticoagulation during ECMO. This article is freely available.<\/jats:p>","DOI":"10.1007\/s00063-024-01116-0","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:02:33Z","timestamp":1709870553000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Between a\u00a0rock and a\u00a0hard place: anticoagulation management for ECMO","Zwischen Skylla und Charybdis: Antikoagulationsmangement bei ECMO"],"prefix":"10.1007","volume":"119","author":[{"given":"Nina","family":"Buchtele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"2","key":"1116_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","volume":"21","author":"J Helms","year":"2023","unstructured":"Helms\u00a0J, Frere\u00a0C, Thiele\u00a0T, Tanaka\u00a0KA, Neal\u00a0MD, Steiner\u00a0ME et\u00a0al (2023) Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J\u00a0Thromb Haemost 21(2):373\u2013396","journal-title":"J Thromb Haemost"},{"issue":"5","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1097\/CCM.0000000000004286","volume":"48","author":"T Granja","year":"2020","unstructured":"Granja\u00a0T, Hohenstein\u00a0K, Schussel\u00a0P, Fischer\u00a0C, Prufer\u00a0T, Schibilsky\u00a0D et\u00a0al (2020) Multi-modal characterization of the coagulopathy associated with extracorporeal membrane oxygenation. Crit Care Med 48(5):e400\u2013e408","journal-title":"Crit Care Med"},{"issue":"3","key":"1116_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/MAT.0b013e318213f9e0","volume":"57","author":"T Bein","year":"2011","unstructured":"Bein\u00a0T, Zimmermann\u00a0M, Philipp\u00a0A, Ramming\u00a0M, Sinner\u00a0B, Schmid\u00a0C et\u00a0al (2011) Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO\u00a0J 57(3):164\u2013168","journal-title":"ASAIO J"},{"issue":"2","key":"1116_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1164\/rccm.202110-2359OC","volume":"206","author":"N Buchtele","year":"2022","unstructured":"Buchtele\u00a0N, Schorgenhofer\u00a0C, Schwameis\u00a0M, Jilma\u00a0B, Schellongowski\u00a0P, Herkner\u00a0H et\u00a0al (2022) Add-on prostaglandin E(1) in venovenous extracorporeal membrane oxygenation: a\u00a0randomized, double-blind, placebo-controlled pilot trial. Am J Respir Crit Care Med 206(2):170\u2013177","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1116_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1160\/TH15-08-0687","volume":"115","author":"JH Levy","year":"2016","unstructured":"Levy\u00a0JH, Sniecinski\u00a0RM, Welsby\u00a0IJ, Levi\u00a0M (2016) Antithrombin: anti-inflammatory properties and clinical application. Thromb Haemost 115(4):712\u2013728","journal-title":"Thromb Haemost"},{"issue":"3","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/ALN.0000000000003044","volume":"132","author":"A Protti","year":"2020","unstructured":"Protti\u00a0A, Iapichino\u00a0GE, Di Nardo\u00a0M, Panigada\u00a0M, Gattinoni\u00a0L (2020) Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation: a\u00a0worldwide survey. Anesthesiology 132(3):562\u2013570","journal-title":"Anesthesiology"},{"issue":"3","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","volume":"68","author":"ABV McMichael","year":"2022","unstructured":"McMichael\u00a0ABV, Ryerson\u00a0LM, Ratano\u00a0D, Fan\u00a0E, Faraoni\u00a0D, Annich\u00a0GM (2022) 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO\u00a0J 68(3):303\u2013310","journal-title":"ASAIO J"},{"issue":"8","key":"1116_CR8","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/01.ATV.17.8.1568","volume":"17","author":"E Young","year":"1997","unstructured":"Young\u00a0E, Podor\u00a0TJ, Venner\u00a0T, Hirsh\u00a0J (1997) Induction of the acute-phase reaction increases heparin-binding proteins in plasma. Arterioscler Thromb Vasc Biol 17(8):1568\u20131574","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1116_CR9","doi-asserted-by":"crossref","unstructured":"Levy JH, Sniecinski RM, Rocca B, Ghadimi K, Douketis J, Frere C et\u00a0al (2023) Defining heparin resistance: communication from the ISTH SSC subcommittee of perioperative and critical care thrombosis and hemostasis. J\u00a0Thromb Haemost","DOI":"10.1016\/j.jtha.2023.08.013"},{"issue":"1","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13054-023-04612-5","volume":"27","author":"SJ Raasveld","year":"2023","unstructured":"Raasveld\u00a0SJ, van den Oord\u00a0C, Schenk\u00a0J, van den Bergh\u00a0WM, Oude Lansink-Hartgring\u00a0A, van der Velde\u00a0F et\u00a0al (2023) The interaction of thrombocytopenia, hemorrhage, and platelet transfusion in venoarterial extracorporeal membrane oxygenation: a\u00a0multicenter observational study. Crit Care 27(1):321","journal-title":"Crit Care"},{"issue":"4","key":"1116_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jth.12852","volume":"13","author":"DM Arnold","year":"2015","unstructured":"Arnold\u00a0DM, Curtis\u00a0BR, Bakchoul\u00a0T (2015) Platelet Immunology Scientific Subcommittee of the International Society on T, Hemostasis. Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH. J\u00a0Thromb Haemost 13(4):676\u2013678","journal-title":"J Thromb Haemost"},{"issue":"9","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s00134-018-5346-y","volume":"44","author":"A Kimmoun","year":"2018","unstructured":"Kimmoun\u00a0A, Oulehri\u00a0W, Sonneville\u00a0R, Grisot\u00a0PH, Zogheib\u00a0E, Amour\u00a0J et\u00a0al (2018) Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a\u00a0retrospective nationwide study. Intensive Care Med 44(9):1460\u20131469","journal-title":"Intensive Care Med"},{"issue":"5","key":"1116_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1160\/TH09-05-0306","volume":"103","author":"S He","year":"2010","unstructured":"He\u00a0S, Blomback\u00a0M, Bark\u00a0N, Johnsson\u00a0H, Wallen\u00a0NH (2010) The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. Thromb Haemost 103(5):1076\u20131084","journal-title":"Thromb Haemost"},{"issue":"1","key":"1116_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12959-022-00401-2","volume":"20","author":"R M\u2019Pembele","year":"2022","unstructured":"M\u2019Pembele\u00a0R, Roth\u00a0S, Metzger\u00a0A, Nucaro\u00a0A, Stroda\u00a0A, Polzin\u00a0A et\u00a0al (2022) Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a\u00a0systematic review and meta-analysis. Thromb\u00a0J 20(1):42","journal-title":"Thromb J"},{"issue":"3","key":"1116_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0049-3848(00)00397-2","volume":"101","author":"M Elg","year":"2001","unstructured":"Elg\u00a0M, Carlsson\u00a0S, Gustafsson\u00a0D (2001) Effect of activated prothrombin complex concentrate or recombinant factor\u00a0VIIa on the bleeding time and thrombus formation during anticoagulation with a\u00a0direct thrombin inhibitor. Thromb Res 101(3):145\u2013157","journal-title":"Thromb Res"},{"key":"1116_CR16","doi-asserted-by":"crossref","unstructured":"Cohan D, Uricchio MN, Konopka CI, Montepara CA, Verlinden NJ (2023) Comparison of clinical outcomes with cangrelor plus aspirin versus oral dual antiplatelet therapy in patients supported with venoarterial extracorporeal membrane oxygenation. Artif Organs","DOI":"10.1111\/aor.14590"},{"key":"1116_CR17","doi-asserted-by":"crossref","unstructured":"Helms J, Curtiaud A, Severac F, Merdji H, Angles-Cano E (2023) Dynamic longitudinal increase in D\u2011dimers: an early predictor of bleeding complications in ECMO. Intensive Care Med","DOI":"10.1007\/s00134-023-07224-3"},{"issue":"5","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/vox.12514","volume":"112","author":"SA Esper","year":"2017","unstructured":"Esper\u00a0SA, Welsby\u00a0IJ, Subramaniam\u00a0K, John Wallisch\u00a0W, Levy\u00a0JH, Waters\u00a0JH et\u00a0al (2017) Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques. Vox Sang 112(5):443\u2013452","journal-title":"Vox Sang"},{"issue":"Suppl 6","key":"1116_CR19","first-page":"S1","volume":"60","author":"T Carll","year":"2020","unstructured":"Carll\u00a0T, Wool\u00a0GD (2020) Basic principles of viscoelastic testing. Transfusion 60(Suppl 6):S1\u2013S9","journal-title":"Transfusion"},{"issue":"9","key":"1116_CR20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/aor.13467","volume":"43","author":"J Khan","year":"2019","unstructured":"Khan\u00a0J, Chandler\u00a0WL (2019) Interference in the anti-Xa heparin activity assay due to hemolysis and icterus during pediatric extracorporeal life support. Artif Organs 43(9):880\u2013887","journal-title":"Artif Organs"},{"issue":"5","key":"1116_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0267659120952982","volume":"36","author":"A Willems","year":"2021","unstructured":"Willems\u00a0A, Roeleveld\u00a0PP, Labarinas\u00a0S, Cyrus\u00a0JW, Muszynski\u00a0JA, Nellis\u00a0ME et\u00a0al (2021) Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a\u00a0systematic review and meta-analysis. Perfusion 36(5):501\u2013512","journal-title":"Perfusion"},{"issue":"2","key":"1116_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/ijlh.13757","volume":"44","author":"S Guy","year":"2022","unstructured":"Guy\u00a0S, Kitchen\u00a0S, Hopkins\u00a0B, Chunara\u00a0Z, Stephenson-Brown\u00a0A, van Veen\u00a0JJ (2022) Laboratory methods for monitoring argatroban in heparin-induced thrombocytopenia. Int J Lab Hematol 44(2):399\u2013406","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"1116_CR23","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1007\/s00134-015-4015-7","volume":"41","author":"HJ Yeo","year":"2015","unstructured":"Yeo\u00a0HJ, Kim\u00a0DH, Jeon\u00a0D, Kim\u00a0YS, Cho\u00a0WH (2015) Low-dose heparin during extracorporeal membrane oxygenation treatment in adults. Intensive Care Med 41(11):2020\u20132021","journal-title":"Intensive Care Med"},{"issue":"8","key":"1116_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00134-022-06794-y","volume":"48","author":"A Mansour","year":"2022","unstructured":"Mansour\u00a0A, Flecher\u00a0E, Schmidt\u00a0M, Rozec\u00a0B, Gouin-Thibault\u00a0I, Esvan\u00a0M et\u00a0al (2022) Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a\u00a0nationwide cohort study. Intensive Care Med 48(8):1039\u20131052","journal-title":"Intensive Care Med"},{"issue":"2","key":"1116_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","volume":"48","author":"JI Nunez","year":"2022","unstructured":"Nunez\u00a0JI, Gosling\u00a0AF, O\u2019Gara\u00a0B, Kennedy\u00a0KF, Rycus\u00a0P, Abrams\u00a0D et\u00a0al (2022) Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis. Intensive Care Med 48(2):213\u2013224","journal-title":"Intensive Care Med"},{"issue":"11","key":"1116_CR26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jchf.2020.09.004","volume":"8","author":"M Chung","year":"2020","unstructured":"Chung\u00a0M, Cabezas\u00a0FR, Nunez\u00a0JI, Kennedy\u00a0KF, Rick\u00a0K, Rycus\u00a0P et\u00a0al (2020) Hemocompatibility-related adverse events and survival on venoarterial extracorporeal life support: an ELSO registry analysis. JACC Heart Fail 8(11):892\u2013902","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1116_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/aor.14395","volume":"47","author":"C Atchison","year":"2023","unstructured":"Atchison\u00a0C, Widdershins\u00a0A, Chandler\u00a0WL (2023) Causes of platelet loss during extracorporeal life support. Artif Organs 47(1):160\u2013167","journal-title":"Artif Organs"},{"issue":"11","key":"1116_CR28","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","volume":"48","author":"M Panigada","year":"2020","unstructured":"Panigada\u00a0M, Cucino\u00a0A, Spinelli\u00a0E, Occhipinti\u00a0G, Panarello\u00a0G, Novembrino\u00a0C et\u00a0al (2020) A\u00a0randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation. Crit Care Med 48(11):1636\u20131644","journal-title":"Crit Care Med"},{"issue":"4","key":"1116_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/jth.13960","volume":"16","author":"J Sokol","year":"2018","unstructured":"Sokol\u00a0J, Timp\u00a0JF, le Cessie\u00a0S, van Hylckama-Vlieg\u00a0A, Rosendaal\u00a0FR, Kubisz\u00a0P et\u00a0al (2018) Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study. J\u00a0Thromb Haemost 16(4):680\u2013688","journal-title":"J Thromb Haemost"},{"issue":"8","key":"1116_CR30","doi-asserted-by":"publisher","first-page":"e0949","DOI":"10.1097\/CCE.0000000000000949","volume":"5","author":"MMT van Haeren","year":"2023","unstructured":"van Haeren\u00a0MMT, Raasveld\u00a0SJ, Karami\u00a0M, Miranda\u00a0DDR, Mandigers\u00a0L, Dauwe\u00a0DF et\u00a0al (2023) Plasma transfusion and procoagulant product administration in extracorporeal membrane oxygenation: a\u00a0secondary analysis of an international observational study on current practices. Crit Care Explor 5(8):e949","journal-title":"Crit Care Explor"},{"issue":"5","key":"1116_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/MAT.0000000000000525","volume":"63","author":"C Lotz","year":"2017","unstructured":"Lotz\u00a0C, Streiber\u00a0N, Roewer\u00a0N, Lepper\u00a0PM, Muellenbach\u00a0RM, Kredel\u00a0M (2017) Therapeutic interventions and risk factors of bleeding during extracorporeal membrane oxygenation. ASAIO\u00a0J 63(5):624\u2013630","journal-title":"ASAIO J"},{"issue":"23","key":"1116_CR32","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran\u00a0R, Rao\u00a0SV, Bhatt\u00a0DL, Gibson\u00a0CM, Caixeta\u00a0A, Eikelboom\u00a0J et\u00a0al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a\u00a0consensus report from the Bleeding Academic Research Consortium. Circulation 123(23):2736\u20132747","journal-title":"Circulation"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01116-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01116-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01116-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T08:02:34Z","timestamp":1732262554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01116-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":32,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01116-0","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.\u00a0Buchtele and J.H.\u00a0Levy declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}